Lantern Pharma(LTRN)
icon
搜索文档
Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exon 21 L858R Lung Cancer
Businesswire· 2026-06-02 20:13
公司动态 - 公司以8-K表格形式提交了一份演示文稿 [1]